Ask a Question
Coherent
Search Results
37 - 48 of 164 Products for 'ela' Page 4 of 14 |

ela

FCO Decision

FCO Decision

…exchange rate fluctuations. Compared to the previous quarter, net sales decreased $15.2 million or 7.5% which is partially due to the Linebeam 1500 ELA system shift to the fourth quarter and a slowdown in semiconductor investments. In addition, our medical ophthalmic revenues declined following a…

FCO Decision

FCO Decision

…with revenues of $188.5 million and pro forma earnings of $0.82 per diluted share. The third quarter revenue does not include the third LB 1500 ELA system that we had previously indicated may ship in the third quarter. The customer requested that we deliver this unit in the fourth quarter, as…

FCO Decision

FCO Decision

…exchange rate fluctuations. Compared to the previous quarter, net sales decreased $15.2 million or 7.5% which is partially due to the Linebeam 1500 ELA system shift to the fourth quarter and a slowdown in semiconductor investments. In addition, our medical ophthalmic revenues declined following a…

FCO Decision

FCO Decision

…with revenues of $188.5 million and pro forma earnings of $0.82 per diluted share. The third quarter revenue does not include the third LB 1500 ELA system that we had previously indicated may ship in the third quarter. The customer requested that we deliver this unit in the fourth quarter, as…

FCO Decision

FCO Decision

…exchange rate fluctuations. Compared to the previous quarter, net sales decreased $15.2 million or 7.5% which is partially due to the Linebeam 1500 ELA system shift to the fourth quarter and a slowdown in semiconductor investments. In addition, our medical ophthalmic revenues declined following a…

FCO Decision

FCO Decision

…with revenues of $188.5 million and pro forma earnings of $0.82 per diluted share. The third quarter revenue does not include the third LB 1500 ELA system that we had previously indicated may ship in the third quarter. The customer requested that we deliver this unit in the fourth quarter, as…

FCO Decision

FCO Decision

…exchange rate fluctuations. Compared to the previous quarter, net sales decreased $15.2 million or 7.5% which is partially due to the Linebeam 1500 ELA system shift to the fourth quarter and a slowdown in semiconductor investments. In addition, our medical ophthalmic revenues declined following a…

FCO Decision

FCO Decision

…with revenues of $188.5 million and pro forma earnings of $0.82 per diluted share. The third quarter revenue does not include the third LB 1500 ELA system that we had previously indicated may ship in the third quarter. The customer requested that we deliver this unit in the fourth quarter, as…

FCO Decision

FCO Decision

…exchange rate fluctuations. Compared to the previous quarter, net sales decreased $15.2 million or 7.5% which is partially due to the Linebeam 1500 ELA system shift to the fourth quarter and a slowdown in semiconductor investments. In addition, our medical ophthalmic revenues declined following a…

Lasers-Enable-Smartphone-Manufacturing.pdf

Lasers-Enable-Smartphone-Manufacturing.pdf

…In response, Coherent developed the Vyper series of excimer lasers to deliver a suitable pulse energy/ repetition rate for ELA. And Coherent's latest flagship product for ELA (Figure 7) mates the 1.2 kW 308 nm Vyper excimer laser together with 750 mm length LineBeam optics to deliver a scalable…

Lasers-Enable-Smartphone-Manufacturing.pdf

Lasers-Enable-Smartphone-Manufacturing.pdf

…In response, Coherent developed the Vyper series of excimer lasers to deliver a suitable pulse energy/ repetition rate for ELA. And Coherent's latest flagship product for ELA (Figure 7) mates the 1.2 kW 308 nm Vyper excimer laser together with 750 mm length LineBeam optics to deliver a scalable…

Lasers-Enable-Smartphone-Manufacturing.pdf

Lasers-Enable-Smartphone-Manufacturing.pdf

…In response, Coherent developed the Vyper series of excimer lasers to deliver a suitable pulse energy/ repetition rate for ELA. And Coherent's latest flagship product for ELA (Figure 7) mates the 1.2 kW 308 nm Vyper excimer laser together with 750 mm length LineBeam optics to deliver a scalable…

Powered by Site Search powered by SLI Systems

Call 1-800-227-8840


Outside the U.S. 1-408-764-4983

Coherent has locations across the globe that are available to provide support for any product, service or inquiry.

Visit our Contact Page to connect with any of our global sites.


Corporate Headquarters
Coherent Inc.
5100 Patrick Henry Drive
Santa Clara, CA 95054 USA

email: tech.sales@coherent.com

Send Us a Message

Please Read Before Continuing

Risk factors: Except for the historical information contained here, many of the matters discussed in this Web site are forward-looking statements, based on expectations at the time they were made, that involve risks and uncertainties that could cause our results to differ materially from those expressed or implied by such statements. These risks are detailed in the “Factors That May Affect Future Results” section of our latest 10-K or 10-Q filing. Coherent assumes no obligation to update these forward-looking statements.


I have read the terms and conditions